Today
+2.15%
5 Days
+6.87%
1 Month
-1.56%
6 Months
+23.21%
Year to Date
+62.73%
1 Year
+141.03%
• ASML benefits from increased semiconductor capital expenditure and demand for High-NA EUV technology. • Moderating interest rates and stable export regulations support the company’s current valuation multiples. • Technical indicators suggest mixed signals while analysts maintain a bullish outlook on margins.
• ASML orders are increasing due to demand for next-generation lithography systems. • Analysts revised price targets upward following improved gross margin projections for the company. • Technical indicators currently show a MACD sell signal and oversold Williams %R conditions.
• Potential U.S. export restrictions create uncertainty for ASML's international market access and revenue. • Major semiconductor clients are slowing capital expenditure for next-generation production capacity expansion. • Analyst price target revisions and increased R&D spending are pressuring company valuation margins.
• U.S. export restrictions on China threaten ASML's revenue and service backlog. • Market concerns regarding next-generation tool adoption delay anticipated sector recovery. • Macroeconomic inflationary pressures and interest rate expectations drive increased selling volatility.
• ASML reported strong quarterly earnings driven by high demand for advanced lithography systems. • Analysts increased price targets citing long-term revenue visibility and robust semiconductor equipment orders. • Improving gross margin outlooks and broader sector optimism support the company’s valuation growth.
• AI-driven demand for advanced node capacity is accelerating semiconductor equipment investments. • Institutional investors are increasing positions ahead of anticipated positive earnings updates. • Analysts raised price targets following improved gross margin projections for the year.


| Shareholders | Proportion |
|---|---|
| Fisher Investments | 1.19% |
| Capital World Investors | 1.01% |
| Capital International Investors | 0.88% |
| State Farm Insurance Companies | 0.77% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 9.54% |
| Investment Advisor/Hedge Fund | 5.78% |
| Research Firm | 1.13% |
| Hedge Fund | 0.99% |
Related Instruments
Popular Instruments